Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Assets (2020 - 2025)

BioAtla (BCAB) has 6 years of Current Assets data on record, last reported at $9.7 million in Q3 2025.

  • For Q3 2025, Current Assets fell 84.03% year-over-year to $9.7 million; the TTM value through Sep 2025 reached $9.7 million, down 84.03%, while the annual FY2024 figure was $51.2 million, 55.99% down from the prior year.
  • Current Assets reached $9.7 million in Q3 2025 per BCAB's latest filing, down from $20.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $273.5 million in Q3 2021 and bottomed at $9.7 million in Q3 2025.
  • Average Current Assets over 5 years is $145.5 million, with a median of $175.3 million recorded in 2023.
  • Peak YoY movement for Current Assets: rose 2.75% in 2021, then plummeted 84.03% in 2025.
  • A 5-year view of Current Assets shows it stood at $247.3 million in 2021, then dropped by 10.86% to $220.4 million in 2022, then crashed by 47.19% to $116.4 million in 2023, then tumbled by 55.99% to $51.2 million in 2024, then tumbled by 81.13% to $9.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $9.7 million in Q3 2025, $20.6 million in Q2 2025, and $37.5 million in Q1 2025.